Collection 03 June 2015

Proceedings of the 7th International Symposium: Haploidentical Hematopoietic Stem Cell Transplantation

The symposium was held at the Weizmann Institute of Science, Rehovot, Israel, 9-10 February 2014. Publication of this supplement was supported by WIS-CSP Foundation, in collaboration with Gilead, Milteny Biotec, Gamida cell, Adienne Pharma and Biotech, Medac hematology, Kiadis Pharma, Almog Diagnostic.

Overview

Haploidentical hematopoietic stem cell transplantation: state of art
- Y Reisner
- F Aversa
- M F Martelli
Overview3 Jun 2015 Bone Marrow Transplantation

T Cell Depleted Haplo Transplants

Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients
- P Lang
- T Feuchtinger
- R Handgretinger
Original Article3 Jun 2015 Bone Marrow Transplantation
T-cell depletion: from positive selection to negative depletion in adult patients
- F Aversa
Original Article3 Jun 2015 Bone Marrow Transplantation
The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT
- N Or-Geva
- Y Reisner
Original Article3 Jun 2015 Bone Marrow Transplantation

T Cell Replete Haplo Transplants: G-CSF bone marrow

Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation
- Y-J Chang
- X-J Huang
Review3 Jun 2015 Bone Marrow Transplantation
Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update
- W Arcese
- A Picardi
- on behalf of Rome Transplant Network
Original Article3 Jun 2015 Bone Marrow Transplantation

T Cell Replete Haplo Transplants: Cyclophosphamide post-transplant

HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide
- E J Fuchs
Original Article3 Jun 2015 Bone Marrow Transplantation
Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update
- A Bacigalupo
- A Dominietto
- A M Raiola
Original Article3 Jun 2015 Bone Marrow Transplantation
Who is the best alternative allotransplant donor?
- R P Gale
- M Eapen
Original Article3 Jun 2015 Bone Marrow Transplantation

Proceedings of the 7th International Symposium: Haploidentical Hematopoietic Stem Cell Transplantation

Overview

Haploidentical hematopoietic stem cell transplantation: state of art

T Cell Depleted Haplo Transplants

Improved immune recovery after transplantation of TCRαβ/CD19-depleted allografts from haploidentical donors in pediatric patients

T-cell depletion: from positive selection to negative depletion in adult patients

The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT

T Cell Replete Haplo Transplants: G-CSF bone marrow

Improving the clinical outcome of unmanipulated haploidentical blood and marrow transplantation

Haploidentical, G-CSF-primed, unmanipulated bone marrow transplantation for patients with high-risk hematological malignancies: an update

T Cell Replete Haplo Transplants: Cyclophosphamide post-transplant

HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide

Unmanipulated haploidentical bone marrow transplantation and post-transplant cyclophosphamide for hematologic malignanices following a myeloablative conditioning: an update

Who is the best alternative allotransplant donor?

Search

Quick links